Objective: Thymic carcinoma is a rare thymic neoplasm. It is more invasive
and has a poorer prognosis than thymoma. We report our experience in the tr
eatment of 13 thymic carcinomas.
Methods: Thirteen patients with histologically confirmed thymic carcinoma w
ere treated from June 1989. Six patients underwent surgery, followed by adj
uvant therapy. Seven patients underwent neoadjuvant chemotherapy, followed
by surgery and post-operative radiotherapy.
Results: The diagnosis of thymic carcinoma was achieved in six cases by a m
ediastinotomy, in three cases by a ultrasound-guided or a CT-guided fine ne
edle aspiration and in three cases the pre-operative diagnosis was thymoma.
In one case we did not have the histological diagnosis. All seven patients
treated with neoadjuvant chemotherapy responded. The surgical resection wa
s complete in seven cases. Eight patients are still alive 8-142 months from
the diagnosis, and six are disease-free.
Conclusions: Our experience supports the role of surgery and post-operative
radiotherapy in thymic carcinomas. Pre-operative treatment of such neoplas
ms by multi-drug chemotherapy may improve the resectability and the surviva
l rate. (C) 2001 Harcourt Publishers Ltd.